Boston Scientific Corp Stock Buy Hold or Sell Recommendation
| BSX Stock | USD 72.91 3.92 5.68% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Boston Scientific Corp is 'Strong Buy'. Macroaxis provides Boston Scientific buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BSX positions. The advice algorithm takes into account all of Boston Scientific's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Boston Scientific's buy or sell advice are summarized below:
Real Value 71.93 | Target Price 61.18 | Hype Value 73.03 | Market Value 72.91 | Naive Value 72.89 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Boston Scientific Corp given historical horizon and risk tolerance towards Boston Scientific. When Macroaxis issues a 'buy' or 'sell' recommendation for Boston Scientific Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Boston |
Execute Boston Scientific Buy or Sell Advice
The Boston recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Boston Scientific Corp. Macroaxis does not own or have any residual interests in Boston Scientific Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Boston Scientific's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Solid | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Very Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Boston Scientific Trading Alerts and Improvement Suggestions
| Boston Scientific is unlikely to experience financial distress in the next 2 years | |
| Boston Scientific has a very strong financial position based on the latest SEC filings | |
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from ajc.com: Stock market today Tesla cruises higher as most of Wall Street drifts in mixed trading |
Boston Scientific Returns Distribution Density
The distribution of Boston Scientific's historical returns is an attempt to chart the uncertainty of Boston Scientific's future price movements. The chart of the probability distribution of Boston Scientific daily returns describes the distribution of returns around its average expected value. We use Boston Scientific Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Boston Scientific returns is essential to provide solid investment advice for Boston Scientific.
| Mean Return | 0.28 | Value At Risk | -1.15 | Potential Upside | 2.07 | Standard Deviation | 1.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Boston Scientific historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Boston Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Boston Scientific is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Boston Scientific Corp backward and forwards among themselves. Boston Scientific's institutional investor refers to the entity that pools money to purchase Boston Scientific's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bollard Group Llc | 2023-12-31 | 22.4 M | Citadel Advisors Llc | 2023-09-30 | 21.2 M | Dz Bank Ag Deutsche Zentral-genossenschaftsbank Frankfurt Am Main | 2023-12-31 | 21.1 M | Hhg Plc | 2023-12-31 | 19.5 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 18.8 M | Artisan Partners Limited Partnership | 2023-12-31 | 17.2 M | Bank Of New York Mellon Corp | 2023-12-31 | 17 M | Norges Bank | 2023-12-31 | 16.1 M | Northern Trust Corp | 2023-12-31 | 13.7 M | Fmr Inc | 2023-12-31 | 138.3 M | Blackrock Inc | 2023-12-31 | 126.6 M |
Boston Scientific Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (290M) | (65M) | (346M) | (321M) | (660M) | (627M) | |
| Change In Cash | (222M) | 1.4B | 173M | (1.0B) | (71M) | (67.5M) | |
| Free Cash Flow | 1.4B | 1.1B | 1.3B | 914M | 1.7B | 1.8B | |
| Depreciation | 1.0B | 1.1B | 1.1B | 1.1B | 1.2B | 1.3B | |
| Other Non Cash Items | 551M | 337M | 17M | 540M | 253M | 438.3M | |
| Net Income | 4.7B | (82M) | 1.0B | 698M | 1.6B | 1.7B | |
| End Period Cash Flow | 607M | 2.0B | 2.2B | 1.1B | 1.1B | 673.8M | |
| Investments | (348M) | (146M) | 15M | 56M | (1.7B) | (1.6B) | |
| Change Receivables | (130M) | 335M | (279M) | (220M) | (198M) | (188.1M) | |
| Net Borrowings | 1.4B | 2.8B | (999M) | (165M) | (189.8M) | (180.3M) | |
| Change To Netincome | 312M | 205M | 100M | 410M | 369M | 516.1M |
Boston Scientific Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Boston Scientific or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Boston Scientific's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Boston stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.23 | |
β | Beta against NYSE Composite | 0.51 | |
σ | Overall volatility | 1.21 | |
Ir | Information ratio | 0.16 |
Boston Scientific Volatility Alert
Boston Scientific Corp has low volatility with Treynor Ratio of 0.54, Maximum Drawdown of 5.27 and kurtosis of 5.56. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Boston Scientific's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Boston Scientific's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Boston Scientific Fundamentals Vs Peers
Comparing Boston Scientific's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Boston Scientific's direct or indirect competition across all of the common fundamentals between Boston Scientific and the related equities. This way, we can detect undervalued stocks with similar characteristics as Boston Scientific or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Boston Scientific's fundamental indicators could also be used in its relative valuation, which is a method of valuing Boston Scientific by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Boston Scientific to competition |
| Fundamentals | Boston Scientific | Peer Average |
| Return On Equity | 0.0858 | -0.31 |
| Return On Asset | 0.0447 | -0.14 |
| Profit Margin | 0.11 % | (1.27) % |
| Operating Margin | 0.17 % | (5.51) % |
| Current Valuation | 110.17 B | 16.62 B |
| Shares Outstanding | 1.47 B | 571.82 M |
| Shares Owned By Insiders | 0.19 % | 10.09 % |
| Shares Owned By Institutions | 94.46 % | 39.21 % |
| Number Of Shares Shorted | 12.43 M | 4.71 M |
| Price To Earning | 107.05 X | 28.72 X |
| Price To Book | 5.19 X | 9.51 X |
| Price To Sales | 7.03 X | 11.42 X |
| Revenue | 14.24 B | 9.43 B |
| Gross Profit | 8.68 B | 27.38 B |
| EBITDA | 3.62 B | 3.9 B |
| Net Income | 1.59 B | 570.98 M |
| Cash And Equivalents | 928 M | 2.7 B |
| Cash Per Share | 0.24 X | 5.01 X |
| Total Debt | 9.49 B | 5.32 B |
| Debt To Equity | 0.51 % | 48.70 % |
| Current Ratio | 1.45 X | 2.16 X |
| Book Value Per Share | 13.15 X | 1.93 K |
| Cash Flow From Operations | 2.5 B | 971.22 M |
| Short Ratio | 2.01 X | 4.00 X |
| Earnings Per Share | 1.07 X | 3.12 X |
| Price To Earnings To Growth | 1.80 X | 4.89 X |
| Target Price | 74.2 | |
| Number Of Employees | 48 K | 18.84 K |
| Beta | 0.79 | -0.15 |
| Market Capitalization | 107.17 B | 19.03 B |
| Total Asset | 35.14 B | 29.47 B |
| Retained Earnings | 819 M | 9.33 B |
| Working Capital | 1.58 B | 1.48 B |
Note: Disposition of 1644 shares by Daniel Brennan of Boston Scientific at 65.82 subject to Rule 16b-3 [view details]
Boston Scientific Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Boston . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Boston Scientific Buy or Sell Advice
When is the right time to buy or sell Boston Scientific Corp? Buying financial instruments such as Boston Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 9.5B | 9.3B | 9.5B | 10.0B | Total Assets | 32.2B | 32.5B | 35.1B | 36.9B |
Use Investing Ideas to Build Portfolios
In addition to having Boston Scientific in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investor Favorites Thematic Idea Now
Investor Favorites
Macroaxis most traded equities with largest long positions over the last 2 years. The Investor Favorites theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investor Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Boston Scientific Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Boston Stock analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.856 | Earnings Share 1.07 | Revenue Per Share 9.8 | Quarterly Revenue Growth 0.149 | Return On Assets 0.0447 |
The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.